KEYTRUDA 25 mg/mL
pembrolizumab · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
No Recall History
Plain English
KEYTRUDA is a injection, solution containing pembrolizumab at 25 mg/mL, taken intravenous. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- KEYTRUDA
- Generic Name
- pembrolizumab
- NDC Code (Product)
0006-3026- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 25 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125514
- Drug Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 01/15/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is KEYTRUDA used for?
KEYTRUDA contains pembrolizumab. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is KEYTRUDA a controlled substance?
KEYTRUDA is not classified as a controlled substance by the DEA.
What is the generic name for KEYTRUDA?
The generic name for KEYTRUDA is pembrolizumab. There are 2 other brand versions of pembrolizumab.
What is the NDC code for KEYTRUDA 25 mg/mL?
The NDC (National Drug Code) for KEYTRUDA 25 mg/mL is 0006-3026, listed by Merck Sharp & Dohme LLC.